rosiptor   Click here for help

GtoPdb Ligand ID: 9249

Synonyms: AQX-1125 | AQX1125
Immunopharmacology Ligand
Compound class: Synthetic organic
Comment: Rosiptor (AQX-1125) is an investigational allosteric activator of the SH2 domain-containing inositol 5'-phosphatase 1, SHIP1 (HGNC gene symbol INPP5D) [3]. SHIP1 is a negative regulatory phosphatase in the PI3K pathway, a signalling pathway that plays a central role in cellular activation, proliferation, and survival, and which is strongly implicated in inflammatory disorders and cancer. Agonists that activate SHIP1 are being actively developed (as alternatives to direct PI3K inhibitors) for their potential anti-inflammatory action. AQX-1125 is claimed in patent WO2014158654, where it appears to be referred to as compound 9 (without the acetate) [1].
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 3
Hydrogen bond donors 3
Rotatable bonds 3
Topological polar surface area 66.48
Molecular weight 321.27
XLogP 3.55
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES NCC1C(CCC2(C1CCC2=C)C)C1(C)CCC(CC1CO)O
Isomeric SMILES NC[C@@H]1[C@H](CC[C@]2([C@H]1CCC2=C)C)[C@@]1(C)CC[C@@H](C[C@@H]1CO)O
InChI InChI=1S/C20H35NO2/c1-13-4-5-17-16(11-21)18(7-9-19(13,17)2)20(3)8-6-15(23)10-14(20)12-22/h14-18,22-23H,1,4-12,21H2,2-3H3/t14-,15+,16+,17+,18+,19-,20+/m1/s1
InChI Key MDEJTPWQNNMAQF-BVMLLJBZSA-N
Immunopharmacology Comments
Rosiptor is a first-in-class clinical-stage SHIP1 activating small molecule drug.
Immunopharmacology Disease
Disease X-Refs Comment References
Atopic dermatitis Disease Ontology: DOID:3310
OMIM: 603165
Phase 2 clinical trial NCT02324972 completed.
Interstitial cystitis Disease Ontology: DOID:13949
Phase 3 study for interstitial cystitis/bladder pain syndrome is ongoing (see NCT02858453).
Chronic obstructive pulmonary disease Disease Ontology: DOID:3083
Phase 3 clinical candidate for COPD.